NASDAQ:SNSS Shareholder News: Investigation over Potential Wrongdoing at Sunesis Pharmaceuticals, Inc.
Certain directors of Sunesis Pharmaceuticals, Inc. are under investigation concerning possible wrongdoing. The investigation was announced for investors in NASDAQ:SNSS shares over potential breaches of fiduciary duties by certain directors at Sunesis Pharmaceuticals, Inc.
View full press release